Par Drugs And Chemicals Limited has informed the Exchange about Action(s) initiated or orders passed
PAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Par Drugs and Chemicals Limited has disclosed that SEBI's Corporation Finance Investigation Department has asked the company to attend a meeting on June 18, 2025 at SEBI Bhavan in Mumbai. The meeting relates to the company's earlier announcement on February 14, 2025 about a Slump Sale agreement with Phal-Jig Fine Chemicals Private Limited, involving transfer of land, building, plant & machinery, and specific current assets and liabilities. SEBI wants to discuss this slump sale transaction further. The communication was received by the company on June 12, 2025 via email. The company has stated that no violations or contraventions have been alleged and there is no financial or operational impact at this stage.
The development signals regulatory scrutiny of the slump sale transaction, which could create uncertainty for shareholders. However, since the company has not been charged with any violation yet and no financial impact has been quantified, the immediate market impact is likely to be limited. Investors should watch for outcomes of the June 18 meeting.